Albendazole is a broad-spectrum anthelmintic. The principal mode of action for albendazole is by its inhibitory effect on tubulin polymerization which results in the loss of cytoplasmic microtubules. This drug is a medication used for the treatment of a variety of parasitic worm infestations. It is useful for giardiasis, trichuriasis, filariasis, neurocysticercosis, hydatid disease, pinworm disease, and ascariasis, among others. It is taken orally. The indication of drug is used for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the Taenia solium, pork tapeworm, and for the treatment of cystic hydatid disease of the lung, liver, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.
MARKET DYNAMICS
The Albendazole Drug market is expected to grow significantly in the coming years, due to rising cases of neurocysticercosis (infection caused by the pork tapeworm in the muscles, brain, and eyes that may cause seizures, brain swelling, and vision problems). Moreover, increasing health care expenditure anticipated to influence the end-user of Fujimycin.
MARKET SCOPE
The "Albendazole Drug Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Albendazole Drug market with detailed market segmentation by type and application. The Albendazole Drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Albendazole Drug market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Albendazole Drug market is segmented on the basis of type and application . Based on Type , the market is segmented into Tablet and Capsules. On the basis of application , the market is categorized as Giardiasis, Trichuriasis, Filariasis, Neurocysticercosis, Hydatid Disease and Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Albendazole Drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Albendazole Drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Albendazole Drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Albendazole Drug market in these regions.
MARKET PLAYERS
The report covers key developments in the Albendazole Drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Albendazole Drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for Albendazole Drug in the global market. Below mentioned is the list of few companies engaged in the Albendazole Drug market.
The report also includes the profiles of key players in Albendazole Drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GlaxoSmithKline
- Hubei Zhongjia-Chem Pharmaceutical
- Hubei Keyi Pharmaceutical
- Changzhou Yabang
- Huazhong Pharmaceutical
- Sequent Scientific
- K.A.Malle Pharmaceuticals
- Fredun Pharmaceuticals
- Ashish Life Science
- AdvaCare Pharma
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.